A Phase 1a trial shows that a single infusion of CRISPR-Cas9 therapy CTX310 achieves 12-month...
Author - Hippocrates Briefs Team
Mitigating Reperfusion Injury and Infarct Size With Dexrazoxane...
The SHIELD-MI trial demonstrates that peri-procedural intravenous dexrazoxane reduces...
Targeting EFHD1 Calcium-Dependent Organellar Contact...
Inhibiting the EFHD1 protein reduces liver inflammation and scarring by up to 60% by blocking a...
Generative AI Integration in Cancer Care: Mapping Applications...
A scoping review in the European Journal of Cancer reveals key evidence gaps in patient...
Gut-Liver Axis Metabolomics Link Microbial Imidazole Propionate...
A Nature Metabolism study reveals that gut bacterial imidazole propionate drives primary sclerosing...
Neurological and Systemic Complications of Varicella Zoster...
A Nature Reviews Disease Primers study highlights that latent varicella zoster virus reactivation...
AI-Enabled Focused Cardiac Ultrasound: Expanding Screening...
A JAMA Cardiology study demonstrates that AI-guided heart ultrasound acquired by novice operators...
Clopidogrel Monotherapy Versus Extended DAPT in High-Ischemic...
The A-CLOSE trial published in NEJM shows extended DAPT reduces major ischemic events, whereas...
Subclinical Leaflet Thrombosis Reductions With NOAC Monotherapy...
The ACASA-TAVI trial published in JAMA shows NOAC monotherapy significantly reduces post-TAVI...
Mitochondrial Aco2 Inhibition and Citrate Export Drive...
Salk Institute researchers revealed that mitochondrial citrate acts as a second messenger in...